![Eamonn Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Eamonn Connolly worked as the Head of the Research Department at BioGaia AB from 2010 to 2011.
He then served as the Chief Scientific Officer at Infant Bacterial Therapeutics AB from 2013 to 2021.
Dr. Connolly obtained an undergraduate degree from The University of Manchester and a doctorate degree from the University of Manchester Institute of Science & Technology.
Anciens postes connus de Eamonn Connolly
| Sociétés | Poste | Fin |
|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Directeur Technique/Scientifique/R&D | 01/01/2021 |
| BIOGAIA AB | Directeur Technique/Scientifique/R&D | - |
Formation de Eamonn Connolly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioGaia AB
 BioGaia AB Pharmaceuticals: OtherHealth Technology Develops health care products such as foods with healthy additives and provides pharmaceutical research services | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
 University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infant Bacterial Therapeutics AB
 Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
Choisissez Zonebourse 
